NO20011417L - [1,2,4]triazolo[1,5-c]pyrimidin-derivater - Google Patents
[1,2,4]triazolo[1,5-c]pyrimidin-derivaterInfo
- Publication number
- NO20011417L NO20011417L NO20011417A NO20011417A NO20011417L NO 20011417 L NO20011417 L NO 20011417L NO 20011417 A NO20011417 A NO 20011417A NO 20011417 A NO20011417 A NO 20011417A NO 20011417 L NO20011417 L NO 20011417L
- Authority
- NO
- Norway
- Prior art keywords
- represent
- triazolo
- aryl
- pyrimidine derivatives
- lower alkyl
- Prior art date
Links
- QLOWGDIISXJREF-UHFFFAOYSA-N [1,2,4]triazolo[1,5-c]pyrimidine Chemical class C1=CN=CN2N=CN=C21 QLOWGDIISXJREF-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 150000001721 carbon Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 102000007471 Adenosine A2A receptor Human genes 0.000 abstract 1
- 108010085277 Adenosine A2A receptor Proteins 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26717898 | 1998-09-22 | ||
PCT/JP1999/005176 WO2000017201A1 (fr) | 1998-09-22 | 1999-09-22 | DERIVES DE [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011417D0 NO20011417D0 (no) | 2001-03-20 |
NO20011417L true NO20011417L (no) | 2001-05-21 |
Family
ID=17441200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011417A NO20011417L (no) | 1998-09-22 | 2001-03-20 | [1,2,4]triazolo[1,5-c]pyrimidin-derivater |
Country Status (15)
Country | Link |
---|---|
US (1) | US6545000B1 (no) |
EP (1) | EP1116722B1 (no) |
KR (1) | KR20010087361A (no) |
CN (1) | CN1328560A (no) |
AT (1) | ATE286900T1 (no) |
AU (1) | AU756144B2 (no) |
BR (1) | BR9914040A (no) |
CA (1) | CA2344828A1 (no) |
DE (1) | DE69923197T2 (no) |
EA (1) | EA200100265A1 (no) |
HU (1) | HUP0103921A3 (no) |
IL (1) | IL142128A0 (no) |
NO (1) | NO20011417L (no) |
NZ (1) | NZ510629A (no) |
WO (1) | WO2000017201A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002079204A1 (fr) * | 2001-03-28 | 2002-10-10 | Kyowa Hakko Kogyo Co., Ltd. | Derive 8-thiazolyl[1,2,4]triazolo[1,5-c]pyrimidine |
JP5280597B2 (ja) | 2001-03-30 | 2013-09-04 | サンスター技研株式会社 | 一液加熱硬化型エポキシ樹脂組成物および半導体実装用アンダーフィル材 |
JP2005516891A (ja) * | 2001-09-13 | 2005-06-09 | シェーリング コーポレイション | アデノシンA2aレセプタアンタゴニストと抗鬱薬または抗不安薬との組合せ |
AU2002352933A1 (en) * | 2001-11-30 | 2003-06-17 | Schering Corporation | [1,2,4]-triazole bicylic adenosine A2a receptor antagonists |
TW200300686A (en) | 2001-11-30 | 2003-06-16 | Schering Corp | Adenosine A2a receptor antagonists |
US6734179B2 (en) * | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
PL370980A1 (en) * | 2001-12-12 | 2005-06-13 | F.Hoffmann-La Roche Ag | Benzothiophenes as adenosine receptor modulators |
MXPA04007299A (es) | 2002-01-28 | 2004-10-29 | Kyowa Hakko Kogyo Kk | Metodos de tratamiento de pacientes que sufren de trastornos de movimiento. |
AU2003211993A1 (en) * | 2002-02-15 | 2003-09-04 | Kyowa Hakko Kogyo Co., Ltd. | (1,2,4)TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVES |
US20060058320A1 (en) * | 2002-09-24 | 2006-03-16 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4] Triazolo[1,5-c]pyrimidine derivatives |
US20070010522A1 (en) * | 2003-04-09 | 2007-01-11 | Chi Vu | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
WO2004092170A2 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists |
US7674791B2 (en) | 2003-04-09 | 2010-03-09 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
EP1633756B1 (en) | 2003-04-09 | 2008-12-24 | Biogen Idec MA Inc. | A2a adenosine receptor antagonists |
BRPI0411120A (pt) | 2003-06-10 | 2006-07-18 | Kyowa Hakko Kogyo Kk | método para tratar de um distúrbio de ansiedade, composição, agente para tratar de um distúrbio de ansiedade, e, usos de um composto e de um derivado de xantina |
US7851478B2 (en) * | 2005-06-07 | 2010-12-14 | Kyowa Hakko Kirin Co., Ltd. | Agent for preventing and/or treating movement disorder |
EP2089389A2 (en) | 2006-11-01 | 2009-08-19 | Bristol-Myers Squibb Company | Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
TWI473614B (zh) | 2008-05-29 | 2015-02-21 | Kyowa Hakko Kirin Co Ltd | Anti-analgesic inhibitors |
EP2322223A4 (en) * | 2008-07-23 | 2012-08-22 | Kyowa Hakko Kirin Co Ltd | THERAPEUTIC AGENT AGAINST MIGRAINE |
JP5730281B2 (ja) * | 2009-03-27 | 2015-06-10 | 武田薬品工業株式会社 | ポリ(adp−リボース)ポリメラーゼ(parp)阻害剤 |
WO2018166493A1 (zh) | 2017-03-16 | 2018-09-20 | 江苏恒瑞医药股份有限公司 | 杂芳基并[4,3-c]嘧啶-5-胺类衍生物、其制备方法及其在医药上的应用 |
US20190292188A1 (en) | 2018-02-27 | 2019-09-26 | Incyte Corporation | Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors |
CA3100731A1 (en) | 2018-05-18 | 2019-11-21 | Incyte Corporation | Fused pyrimidine derivatives as a2a / a2b inhibitors |
CA3105721A1 (en) | 2018-07-05 | 2020-01-09 | Incyte Corporation | Fused pyrazine derivatives as a2a / a2b inhibitors |
CN110903291B (zh) * | 2018-09-14 | 2021-09-03 | 江苏恒瑞医药股份有限公司 | 一种杂芳基并[4,3-c]嘧啶-5-胺类衍生物的盐、盐的晶型及制备方法 |
TWI829857B (zh) | 2019-01-29 | 2024-01-21 | 美商英塞特公司 | 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4477450A (en) | 1983-03-03 | 1984-10-16 | Riker Laboratories, Inc. | Triazolo [4,3-c]pyrimidines substituted by nitrogen-containing heterocyclic rings |
US4572910A (en) | 1983-03-03 | 1986-02-25 | Riker Laboratories, Inc. | Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings |
US4483987A (en) | 1983-06-20 | 1984-11-20 | G. D. Searle & Co. | 8-Substituted 7-phenyl-1,2,4-triazolo[2,3-c]pyrimidines-5-amines and amides |
NZ208996A (en) | 1983-07-28 | 1989-08-29 | American Cyanamid Co | 5-substituted(1,2,4 triazpyrimidin-2-amine derivatives and pharmaceutical compositions |
EP0459702A1 (en) * | 1990-05-29 | 1991-12-04 | Zeneca Limited | Azole Derivatives |
US5356894A (en) | 1990-05-29 | 1994-10-18 | Rodney Peter W | Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist |
ATE198890T1 (de) * | 1993-09-06 | 2001-02-15 | Kyowa Hakko Kogyo Kk | Antidepressiva |
DE69820866T2 (de) | 1997-03-24 | 2004-12-30 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-DERIVATE |
-
1999
- 1999-09-22 EA EA200100265A patent/EA200100265A1/ru unknown
- 1999-09-22 CN CN99813569A patent/CN1328560A/zh active Pending
- 1999-09-22 AU AU57579/99A patent/AU756144B2/en not_active Ceased
- 1999-09-22 HU HU0103921A patent/HUP0103921A3/hu unknown
- 1999-09-22 DE DE69923197T patent/DE69923197T2/de not_active Expired - Fee Related
- 1999-09-22 CA CA002344828A patent/CA2344828A1/en not_active Abandoned
- 1999-09-22 NZ NZ510629A patent/NZ510629A/xx unknown
- 1999-09-22 US US09/787,779 patent/US6545000B1/en not_active Expired - Fee Related
- 1999-09-22 AT AT99944771T patent/ATE286900T1/de not_active IP Right Cessation
- 1999-09-22 EP EP99944771A patent/EP1116722B1/en not_active Expired - Lifetime
- 1999-09-22 KR KR1020017003599A patent/KR20010087361A/ko not_active Application Discontinuation
- 1999-09-22 IL IL14212899A patent/IL142128A0/xx unknown
- 1999-09-22 WO PCT/JP1999/005176 patent/WO2000017201A1/ja active IP Right Grant
- 1999-09-22 BR BR9914040-3A patent/BR9914040A/pt not_active IP Right Cessation
-
2001
- 2001-03-20 NO NO20011417A patent/NO20011417L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69923197D1 (de) | 2005-02-17 |
EP1116722A4 (en) | 2002-05-29 |
AU5757999A (en) | 2000-04-10 |
BR9914040A (pt) | 2002-01-15 |
US6545000B1 (en) | 2003-04-08 |
EA200100265A1 (ru) | 2001-10-22 |
EP1116722A1 (en) | 2001-07-18 |
AU756144B2 (en) | 2003-01-02 |
WO2000017201A1 (fr) | 2000-03-30 |
KR20010087361A (ko) | 2001-09-15 |
NO20011417D0 (no) | 2001-03-20 |
ATE286900T1 (de) | 2005-01-15 |
EP1116722B1 (en) | 2005-01-12 |
HUP0103921A2 (hu) | 2002-04-29 |
CA2344828A1 (en) | 2000-03-30 |
CN1328560A (zh) | 2001-12-26 |
IL142128A0 (en) | 2002-03-10 |
DE69923197T2 (de) | 2005-12-29 |
HUP0103921A3 (en) | 2002-12-28 |
NZ510629A (en) | 2003-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69923197D1 (de) | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-DERIVATE | |
ES2056096T3 (es) | Purinil-ciclobutanos. | |
ATE79380T1 (de) | 2-substituierte-e-kondensierte(1,2,4>triazolo(1,5-c>pyrimidine, pharmazeutische zubereitungen und ihre verwendung. | |
ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
DE69505470D1 (de) | Pyrrolocarbazol | |
FI900461A0 (fi) | Imidazopyridaziner, deras framstaellning och anvaendning. | |
DK0459505T3 (da) | Imidazonaphthyridinderivater | |
DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
ES2067160T3 (es) | Derivados de 4,5-polimetileno-4-isotiazolina-3-onas y su uso como biocidas. | |
ES2055211T3 (es) | Purinil- y pirimidinil-tetrahidrofuranos. | |
MX9203996A (es) | Preparacion de 2-(2-tienil)etilamina y sintesis de derivados de tieno (3-2-c) piridina a partir de la misma. | |
DK0497695T3 (da) | N-2-chlorbenzyl-2-oxo- og N-2-chlorbenzyl-2,2-dioxo-1,2,3-oxathiazolidinderivater, deres fremstilling samt syntese af thieno/3,2-c/pyridinderivater | |
ES2109936T3 (es) | Derivados de piperacina. | |
DE60103732D1 (de) | Pyrimidinderivate mit antitumor-wirkung | |
EP1148059A4 (en) | THIAZOLPYRIMIDINE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | |
ATE140919T1 (de) | Indolderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |